Description

Flemoclav (Amoxicillin and Clavulanic Acid) Soliutab Tablets 500 mg/125 mg. №20

Ingredients:

Each tablet contains 500 mg of Amoxicillin and 125 mg of Clavulanic Acid.

Dosage:

The usual dose is one tablet every 12 hours. Dosage may vary based on the severity of the infection and should be taken as prescribed by a healthcare provider.

Indications:

Flemoclav Soliutab tablets are indicated for the treatment of various bacterial infections. They are commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and more.

Contraindications:

Do not take Flemoclav if you are allergic to penicillin or cephalosporin antibiotics. Consult your doctor before taking this medication if you have a history of liver problems.

Directions:

Swallow the tablet whole with a full glass of water. It can be taken with or without food. Do not crush or chew the tablet.

Scientific Evidence:

Amoxicillin and clavulanic acid are well-studied antibiotics with a broad spectrum of activity against various bacteria. Research has shown that the combination of these two agents in Flemoclav Soliutab tablets enhances the efficacy of treatment for bacterial infections, especially in cases where the bacteria have developed resistance to other antibiotics.

Additional Information:

Flemoclav Soliutab tablets are formulated as a soluble tablet for easy administration, particularly beneficial for patients who have difficulty swallowing traditional tablets. It is important to complete the full course of treatment as prescribed by the healthcare provider to ensure the infection is fully eradicated and to prevent antibiotic resistance.

Amoxicillin works by inhibiting the synthesis of bacterial cell walls, leading to bacterial cell death. Clavulanic acid, on the other hand, helps in overcoming bacterial resistance by inhibiting certain enzymes that may inactivate amoxicillin. This combination makes Flemoclav effective against a wide range of bacteria.

Clinical trials have demonstrated the effectiveness of Flemoclav in treating various infections, showing high rates of bacterial eradication and clinical improvement. Patients treated with Flemoclav have reported fewer treatment failures and lower rates of recurrence compared to other antibiotics.